CAH · Cardinal Health Inc
$222.50
-1.41 (-0.63%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$52.08B
Shares
232.58M
Volume · Sep 30
1.94M
Avg daily vol (3M)
1.98M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$222.50
Open$223.66
Day$222.07–226.49
52W close$153.27–248.61
Avg vol 30d1.7M
Short int6.7M · 2.9% float · 4.6d
Short vol61%
Last earningsAug 11, 2026
DataJan 2020–Sep 2026
Filing10-K · Aug 11
Up next
Next earnings call
Nov 10, 2026
Est · unconfirmed
· in 6 wks
filed Aug 11, 2026
call held Aug 11, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$244.67B
Trailing 12 months
Net income (TTM)
$1.66B
Trailing 12 months
Revenue growth YoY
+18.8%
Year over year
Operating margin
1.0%
Trailing 12 months
P / E (TTM)
31.3
Trailing earnings · reciprocal yield 3.2%
FCF yield
10.6%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-2.5%
Year over year · fewer shares
Price change (1Y)
+44.9%
Trailing year
Short interest
2.9%
Latest settlement · 4.6 days to cover
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Neutral
Momentum
Neutral
Sentiment
Bullish
Fundamentals
Excellent
Quant / Vol
Moderate
Market backdrop
VIX 16.3 · calm
Equity put/call 0.53
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+2%
above
Price vs 50-day avg
−4%
below
RSI (14)
39
neutral
MACD trend
Negative
52-week position
73%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−7%
trailing
6-month return
+3%
trailing
YTD return
+8%
this year
Relative strength
−9%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $232 › 200d $218 — 50d above 200d
Institutional flow
Accumulating
+5% holders QoQ · +169 funds added
Insider flow
Distributing
Net -$59.6M over 90 days · 100% sells
Short interest
Falling
2.87% of float · ▼ -0.7% MoM · 4.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
1,510 holders — near 3-yr high, broad support
Squeeze score
46
elevated · 0–100
Fundamentals
Revenue growth
+14%
Y/Y
Gross margin
4%
expanding
EPS growth
+12%
Y/Y
Free cash flow
$4.5B
Buyback
$6.4B
authorized
Balance sheet
$4.0B
net debt
Quant / Vol
risk profile
Volatility
29%
annualized · 1-yr
Max drawdown
−21%
past year
ATR
2.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Aug 11, 2026
fiscal 27
EPS
Non-GAAP
Initiated
$12.40 – $12.60
Pharma segment profit growth
Initiated
8% – 11%
GMPD segment profit
Initiated
$200M – $220M
Other growth businesses segment profit growth
Initiated
15% – 18%
Interest and other expenses
Initiated
$240M – $290M
Effective tax rate
Initiated
19% – 20%
Adjusted free cash flow
Non-GAAP
Initiated
$3.5B – $4B
Capital expenditures
Initiated
$700M
Share repurchases
Initiated
at least $1B
long-term
EPS growth
Non-GAAP
12% – 14%
fiscal 2027
Profit growth
Initiated
15% – 18%
each year
Non-GAAP EPS growth
Non-GAAP
12% – 14%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+2%
Bullish
Price vs 50-day avg
−4%
Neutral
RSI (14)
39
Neutral
MACD trend
Negative
Bearish
52-week position
73%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $232 › 200d $218 — 50d above 200d
Institutional flow
Accumulating
+5% holders QoQ · +169 funds added
Insider flow
Distributing
Net -$59.6M over 90 days · 100% sells
Short interest
Falling
2.87% of float · ▼ -0.7% MoM · 4.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
1,510 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $153
Now $223 · 73%
Range high $249
vs 200-day avg +2%
vs 50-day avg -4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Non-GAAP Adjusted Free Cash Flow non-GAAP | $4.97B | Fiscal Year 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net cash provided by operating activities 5.17B
+45M Repurchases of liability-classified Specialty Alliance Units
-649M Additions to property and equipment
+401M Payments related to matters included in litigation (recoveries)/charges, net
= Non-GAAP Adjusted Free Cash Flow 4.97B
|
|||
| Non-GAAP diluted EPS attributable to Cardinal Health, Inc. non-GAAP | $11.26 | FY26 | — |
| Non-GAAP net earnings attributable to Cardinal Health, Inc. non-GAAP | $2.7B | FY26 | — |
| Non-GAAP operating earnings non-GAAP | $3.6B | FY26 | — |
| Operating cash flow | $5.2B | FY26 | — |
| Share repurchase authorization | $6.4B | as of August 2026 | — |
| Share repurchases | $1.4B | FY26 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Distribution — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CAH
this stock
Cardinal Health Inc
|
$52.08B | +8.3% | +14.2% | — | 2.9% |
|
MCK
Mckesson Corp
|
$101.04B | +4.1% | +3.1% | 23.3 | 2.5% |
|
COR
Cencora, Inc.
|
$57.74B | -11.1% | +9.3% | 22.5 | 2.3% |
|
HSIC
Henry Schein Inc
|
$9.63B | +11.1% | +5.9% | 25.2 | 6.8% |
|
EBOSY
EBOS Group Limited/ADR
|
$2.41B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CAH | +0.6% | -7.0% | +3.1% | -5.2% | +8.3% |
| SPY | -0.7% | +0.1% | +12.2% | -0.6% | +11.8% |
| vs SPY | +1.2% | -7.2% | -9.1% | -4.6% | -3.6% |
Capital returns
Latest dividend
$0.5158
/ share · ex Oct 1, 2026
Paid (TTM)
$0.5158
/ share · 1 payout
Dividend yield (TTM, derived)
— · history filling in
Buyback program
· as of Aug 11, 2026
Authorized
$6.40B
Spent (derived)
—
Remaining
—
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
721371
CUSIP
14149Y108
13F (30d)
30 filings
17 filers
Visit website
Investor relations